27 results
S-3
EX-4.3
CARM
Carisma Therapeutics Inc
Shelf registration
17 Apr 23
5:11pm
S-3
EX-4.5
CARM
Carisma Therapeutics Inc
Shelf registration
17 Apr 23
5:11pm
S-3
EX-4.6
CARM
Carisma Therapeutics Inc
Shelf registration
17 Apr 23
5:11pm
S-3
EX-4.4
CARM
Carisma Therapeutics Inc
Shelf registration
17 Apr 23
5:11pm
10-K
2021 FY
EX-4.1
CARM
Carisma Therapeutics Inc
Annual report
28 Feb 22
8:51am
8-K
EX-4.1
eg8r6m08z1k8r558030
29 Oct 19
Sesen Bio Strengthens Strategic and Financial Optionality
4:53pm
8-K
EX-4.2
wzc2d9sl
29 Oct 19
Sesen Bio Strengthens Strategic and Financial Optionality
4:53pm
8-K
EX-4.3
viy4u
29 Oct 19
Sesen Bio Strengthens Strategic and Financial Optionality
4:53pm
8-K
EX-4.4
a91trjso57iinjdu0r
29 Oct 19
Sesen Bio Strengthens Strategic and Financial Optionality
4:53pm
8-K
EX-4.1
h5r0gpd kdm7yhz
19 Jun 19
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-4.1
6ob9fvnh9n 2i2yfe
23 Mar 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
cjtdozgi
3 Nov 17
Eleven Biotherapeutics Prices of $8.0 Million Underwritten Public Offering
12:00am
8-K
EX-4.2
fzbne eukwxq2fkkym
3 Nov 17
Eleven Biotherapeutics Prices of $8.0 Million Underwritten Public Offering
12:00am
8-K
EX-4.1
54qwpw4f i3
21 Sep 16
Eleven Biotherapeutics Acquires Viventia Bio to Create Targeted Protein Therapeutics Oncology Company
12:00am